(Q81094969)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study design (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

2

Günter Breithardt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

Andreas Goette

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Thomas Fetsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Peter Hanrath

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Helmut U Klein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Walter Lehmacher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gerhard Steinbeck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Thomas Meinertz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

697-705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

12 December 2020

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

12 December 2020

Differential Effects of Angiotensin II on Cardiac Cell Proliferation and Intramyocardial Perivascular Fibrosis In Vivo

1 reference

12 December 2020

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

12 December 2020

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

1 reference

12 December 2020

[Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications]

1 reference

12 December 2020

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

1 reference

12 December 2020

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation

1 reference

12 December 2020

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

12 December 2020

Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction

1 reference

12 December 2020

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

1 reference

12 December 2020

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

12 December 2020

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

12 December 2020

Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial

1 reference

12 December 2020

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

12 December 2020

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

12 December 2020

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

12 December 2020

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

12 December 2020

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

12 December 2020

10.2165/00044011-200727100-00005

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803345%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference